Effects of pentoxifylline on coagulation profile and disseminated intravascular coagulation incidence in Egyptian septic neonates

Journal of Clinical Pharmacy and Therapeutics

Volumn 35, Issue 3, 2010, Pages 257-265

  Adel, M ^a   Awad, H A S ^b   Abdel Naim, A B ^c   Al Azizi, M M M ^a  

^a African Union Organization St Abbassia   (Egypt)

^b Faculty of Medicine   (Netherlands)

^c Department of Pharmacology and Toxicology   (Netherlands)

Author keywords

C reactive protein; Coagulation; Disseminated intravascular coagulation; Microcirculation; Multiple organ dysfunction syndrome; Pentoxifylline

Indexed keywords

AMIKACIN; C REACTIVE PROTEIN; CEFOTAXIME; D DIMER; FIBRINOGEN; FRESH FROZEN PLASMA; INOTROPIC AGENT; PENTOXIFYLLINE; PLACEBO; SODIUM CHLORIDE; SULTAMICILLIN; VITAMIN K GROUP;

ARTERIAL PRESSURE; ARTICLE; BLEEDING; BLOOD CELL COUNT; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; CAPILLARY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; DOUBLE BLIND PROCEDURE; EGYPT; ERYTHROCYTE TRANSFUSION; HEART RATE; HEMODYNAMICS; HOSPITALIZATION; HUMAN; INCIDENCE; LENGTH OF STAY; NEWBORN; PARTIAL THROMBOPLASTIN TIME; PERIPHERAL CIRCULATION; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SEPSIS INDUCED MICROCIRCULATORY DERANGEMENT; SIDE EFFECT; SURVIVOR; THERAPY EFFECT; URINE VOLUME;

BLOOD COAGULATION; BLOOD COAGULATION TESTS; DISSEMINATED INTRAVASCULAR COAGULATION; DOUBLE-BLIND METHOD; EGYPT; FEMALE; HEMODYNAMICS; HUMANS; INFANT, NEWBORN; LENGTH OF STAY; MALE; MULTIPLE ORGAN FAILURE; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; SEPSIS;

EID: 77952125009     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2009.01077.x     Document Type: Article

References (32)

1. Philip AGS. (1994) The changing face of neonatal infections, experience at a regional medical centre. Pediatric Infectious Disease Journal, 13, 1098 1102.
2. Bhutta ZA. (1997) Neonatal infections. Current Opinion in Pediatrics, 9, 133 140.
3. Janusz PS. (2002) Immunotherapy in the management of sepsis. Archivum Immunologiae et Therapiae Experimentalisk, 50, 317 324.
4. Hermida J, Montes R, Munoz MC, Orbe J, Paramo JA, Rocha E. (1999) Effects of low molecular weight heparin, alone or combined with antithrombin III, on mortality, fibrin deposits and hemostatic parameters in endotoxin-induced disseminated intravascular coagulation in rabbits. American Journal of Hematology, 60, 6 11. (Pubitemid 28565845)
5. Yamazaki M, Aoshima K, Mizutani T et al. (1999) Prednisolone inhibits endotoxin-induced disseminated intravascular coagulation and improves mortality in rats, Importance of inflammatory cytokine suppression. Blood Coagulation and Fibrinolysis, 10, 321 330. (Pubitemid 29416076)
6. Asakura H, Aoshima K, Suga Y, Yamazaki M, Morishita E, Saito M. (2001) Beneficial effect of the active form of vitamin D3 against LPS-induced DIC but not against tissue-factor-induced DIC in rats. Journal of Thrombosis and Hemostasis, 85, 287 290. (Pubitemid 32140575)
7. Dempfle CE, Pfitzner SA, Dollman M, Huck K, Stehle G, Heene DL. (1995) Comparison of immunological and functional assays for measurement of soluble fibrin. Journal of Thrombosis and Haemostasis, 74, 673 679.
8. Lauterbach R, Zembala M. (1996) Pentoxifylline reduces plasma tumour necrosis factor-alpha concentration in premature infants with sepsis. European Journal of Pediatrics, 155, 404 409. (Pubitemid 26117675)
9. Lauterbach R, Pawlik D, Kowalczyk D, Ksycinski W, Helwich E, Zembala M. (1999) Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants, a placebo-controlled, double-blind trial. Critical Care Medicine, 27, 807 814. (Pubitemid 29218217)
10. Selim K, Huseyin C, Ibrahim KH, Hasan BU, Kazim U, Huseyin K. (2004) Effect of pentoxifylline on tumor necrosis factor-alpha and interleukin-6 levels in neonatal sepsis. Medical Journal of Malaysia, 59, 391 394.
11. Staubach KH, Schröder J, Stuber F, Gehrke K, Traumann E, Zabel P. (1998) Effect of pentoxifylline in severe sepsis, results of a randomized, double-blind, placebo-controlled study. Archives of Surgery, 133, 94 100. (Pubitemid 28053174)
12. Krakauer T, Stiles BG. (1999) Pentoxifylline inhibits superantigen- induced toxic shock and cytokine release. Clinical and Diagnostic Laboratory Immunology, 6, 594 598. (Pubitemid 29330749)
13. Essayan DM. (2001) Cyclic nucleotide phosphodiesterases. Journal of Allergy and Clinical Immunolog, 108, 671 680.
14. Hanna NF. (2003) Sepsis and septic shock. Topics in emergency medicine, 25, 158 165.
15. Leclerc F, Cremer R, Noizet O, Sadik A. (2002) Particularités pédiatriques des coagulations intravasculaires disséminées. Réanimation, 11, 656 666.
16. Bell M, Ternberg J, Feigin R. (1978) Neonatal necrotizing enterocolitis: therapeutic decision based upon clinical staging. Annals of Surgery, 187, 1 7.
17. Col R, Keskin E, Atalay B. (2005) Effect of pentoxifylline on endotoxin-induced haemostatic disturbances in rabbits. Acta Veterinaria Hungarica, 53, 325 335. (Pubitemid 41159792)
18. Turgut B, Vural Ö, Dem M, Kutlu K, Kayapinar R. (2006) Effect of pentoxifylline and indomethacin on rabbits with endotoxin induced disseminated intravascular coagulation (DIC) and comparison with heparin. Turkish Journal of Hematology, 23, 37 46. (Pubitemid 43871121)
19. Boldt J, Muller M, Heyn S, Welters I, Hempelmann G. (1996) Influence of long term continuous intravenous administration of pentoxifylline on endothelial related coagulation in critically ill patients. Critical Care Medicine, 24, 940 946. (Pubitemid 26189933)
20. Connaghan DG, Francis CW, Lane DA. (1985) Specific identification of fibrin polymers, fibrinogen degradation products, and cross link fibrin degradation products in plasma and serum with a new sensitive technique. Blood, 65, 589 597.
21. Gaffney PF, Jespersen J, Muller-Berghaus G. (1985) Monoclonal antibodies against fibrinogen, fibrin and their fragments. Journal of Thrombosis and Haemostasis, 54, 733 734.
22. Rawicz M, Sitkowska B, Rudzinska I, Kornacka MK, Bochenski P. (2002) Recombinant human activated protein C for severe sepsis in a neonate. Medical Science Monitor, 8, CS90 CS94. (Pubitemid 35429228)
23. Oppenheimer L, Hryniuk WM, Bishop AJ. (1976) Thrombocytopenia in severe bacterial infections. Journal of Surgical Research, 20, 211 219.
24. Neame PB, Kelton JG, Walker IR, Stewart IO, Nossel HL, Hirsh J. (1980) Thrombocytopenia in septicemia, the role of disseminated intravascular coagulation. Blood, 56, 88 92. (Pubitemid 10086964)
25. Lissoni P, Ardizzoia A, Barni S, Pittalis S, Rossini F, Porta A, Tancini G. (1996) Characterization of cancer-related disseminated intravascular coagulation in relation to tumor necrosis factor-alpha blood concentrations, possible therapeutic role of pentoxifylline. Tumori, 82, 78 80. (Pubitemid 26147216)
26. Gaviria JM, Dale DC, Root RK. (1998) Neutrophils, Function and role in sepsis syndrome. Sepsis, 2, 107 117. (Pubitemid 128511706)
27. Boldt J, Brosch C, Lehmann A, Haisch G, Lang J, Isgro F. (2001) Prophylactic use of pentoxifylline on inflammation in elderly cardiac surgery patients. The Annals of Thoracic Surgery, 71, 1524 1529.
28. Yang LE, Bohansack J, Hill H. (1993) Fibronectin in host defense. Implication in the diagnosis and prophylaxis and therapy of infectious disease. Pediatric Infectious Disease Journal, 12, 234 239.
29. Parker SJ, Brown D, Kenward CE, Watkins PE. (2000) Pentoxifylline fails to improve organ dysfunction and survival when used in the resuscitation of a porcine model of hemorrhage and abdominal sepsis. Resuscitation, 44, 61 69.
30. Volman TJ, Goris RJ, Hendriks T. (2005) Pentoxifylline does not improve outcome in a murine model for the multiple-organ dysfunction syndrome. Intensive Care Medicine, 31, 701 708.
31. Wajid A, Parvez A, Mushtaq AB, Sheikh M. (2006) Pentoxifylline in treatment of sepsis of premature infants. JK-Practitioner, 13, 204 207.
32. Schröder J, Staubach KH, Stuber F, Zabel P. (1998) Pentoxifylline as adjuvant therapy of multiple organ failure. Langenbecks Archiv für Chirurgie, Supplement, Kongressband, Deutsche Gesellschaft für Chirurgie, Kongress, 115, 461 465.